Search results for: 'battle of the tech gene'
- Did you mean
- battle of the tech g01e
- Related search terms
- the total retail sales of the global apparel retail industry reached 148 billion in 2018 with a compound annual growth rate of 42 from 2014 to 2018
- the current state of the internet of things poised for growth and expansion in (20(2020 2023) organizations are concerned with fund
- The Future of Commercial Vehicle Telematics Market in Japan, Forecast to 2025
- The North American Games Market: Opportunities and Challenges
- The global digital health solutions market for behavioral health management is demonstrating steady and sustained growth, driven
-
18 Dec 2023  |  North America  |  Market Research
Growth Opportunities in the Global Climate Tech Market
Company Profiles for 100 Leading Climate Tech Solutions and Portfolios
The acute impact of climate change due to growing GHG emissions highlights the need for the technologies that can reduce said emissions while preparing the world s population for a scenario in which international targets are not achieved. While mitigation technologies seek to reduce or offset GHG emissions, adaptation technologies prepare communiti...
$2,450.00
Special Price $1,837.50 save 25 %
-
28 Sep 2018  |  North America  |  Technology Research
Gene Editing and Gene Therapy Breakthroughs to Propel Mainstream Disease Treatments
A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present
The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Aug 2022  |  North America  |  Market Research
Global Cell and Gene Therapy (CGT) Growth Opportunities
The Shift to Prevalent Diseases and Allogeneic Cell Therapies Creates New Growth Opportunities in the CGT Value Chain
This Frost & Sullivan study examines the global cell and gene therapy (CGT) market. It highlights revenue forecasts and key growth opportunities for CGT market participants based on the evolution of their business models and strategic approaches as well as investments and regulations. The study segments the market by product (cell therapy, gene-mod...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Feb 2025  |  North America  |  Market Outlook
Top 10 Growth Opportunities in the Global ESG, Sustainability, and Climate Tech Markets, 2025
Tech-driven Designs to Tackle Footprint and Enhance Handprint are Driving Sustainability at Scale, Speed, and Stewardship
The climate emergency and the global economy's pivotal shift to net zero have prompted a need for transparent and accountable environmental, social, and governance (ESG) frameworks that can shape the transition of sustainability and the circular economy. The future of ESG, sustainability, and the circular economy will rely on delivering more with l...
$2,450.00
Special Price $2,205.00 save 10 %
-
04 Feb 2002  |  North America  |  Market Research
U.S. Gene Therapy Market
The U.S. Gene Therapy Market report provides timely information on the emerging gene therapy market. The report examines the overall market in terms of the primary factors driving growth and addresses the key challenges facing the market.
$2,450.00
Special Price $1,837.50 save 25 %
-
16 Nov 2022  |  North America  |  Frost Radar
Frost Radar™: Cell and Gene Therapy Contract Development and Manufacturing Organizations, 2022
A Benchmarking System to Spark Companies to Action-Innovation that Fuels New Deal Flow and Growth Pipelines
As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Aug 2021  |  North America  |  Market Research
US and EU Biotech Industry VC Investment Growth Opportunities
Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI
With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...
$2,450.00
Special Price $1,837.50 save 25 %
-
21 Nov 2016  |  North America  |  Market Research
Global Smart TV and Streaming Media Devices Markets, Forecast to 2021
Competition Sharply Accelerates in the Battle for Conduit to the Big Screen as Consumers Demand Quality Experiences and Ease of Content Delivery
This study provides an in-depth analysis of the global streaming media devices market and the smart TV market. The thin client paradigm, where broadcast, pay TV, and on-demand content is delivered directly via the Internet to consumers, continues to grow. Streaming media devices, smart TVs, and to some extent game consoles and tablets, are at the f...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Nov 2021  |  North America  |  Market Research
Global Naval EO/IR CONOPs Evolutions and Use Cases, 2021
Ability to Capture Data in Multiple Visual Data Bands will Help the Armed Forces Obtain a More Robust Interpretation of the Battle
The naval EO/IR domain will continue to grow and evolve, with countries implementing naval modernization and forcing expansion programs as global tensions rise and as neglected fleets reach their expected end-of-life dates. The need for modern and more capable multi-role fleets comes as European and North American navies become involved within the ...
$2,450.00
Special Price $1,837.50 save 25 %
-
24 Jul 2020  |  North America  |  Market Research
Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024
Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies
With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...
$4,950.00
Special Price $3,712.50 save 25 %